MYO5A_HUMAN - dbPTM
MYO5A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MYO5A_HUMAN
UniProt AC Q9Y4I1
Protein Name Unconventional myosin-Va
Gene Name MYO5A
Organism Homo sapiens (Human).
Sequence Length 1855
Subcellular Localization
Protein Description Processive actin-based motor that can move in large steps approximating the 36-nm pseudo-repeat of the actin filament. Involved in melanosome transport. Also mediates the transport of vesicles to the plasma membrane. May also be required for some polarization process involved in dendrite formation..
Protein Sequence MAASELYTKFARVWIPDPEEVWKSAELLKDYKPGDKVLLLHLEEGKDLEYHLDPKTKELPHLRNPDILVGENDLTALSYLHEPAVLHNLRVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQNMGDMDPHIFAVAEEAYKQMARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEANVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRTYLLEKSRVVFQAEEERNYHIFYQLCASAKLPEFKMLRLGNADNFNYTKQGGSPVIEGVDDAKEMAHTRQACTLLGISESHQMGIFRILAGILHLGNVGFTSRDADSCTIPPKHEPLCIFCELMGVDYEEMCHWLCHRKLATATETYIKPISKLQATNARDALAKHIYAKLFNWIVDNVNQALHSAVKQHSFIGVLDIYGFETFEINSFEQFCINYANEKLQQQFNMHVFKLEQEEYMKEQIPWTLIDFYDNQPCINLIESKLGILDLLDEECKMPKGTDDTWAQKLYNTHLNKCALFEKPRLSNKAFIIQHFADKVEYQCEGFLEKNKDTVFEEQIKVLKSSKFKMLPELFQDDEKAISPTSATSSGRTPLTRTPAKPTKGRPGQMAKEHKKTVGHQFRNSLHLLMETLNATTPHYVRCIKPNDFKFPFTFDEKRAVQQLRACGVLETIRISAAGFPSRWTYQEFFSRYRVLMKQKDVLSDRKQTCKNVLEKLILDKDKYQFGKTKIFFRAGQVAYLEKLRADKLRAACIRIQKTIRGWLLRKKYLRMRKAAITMQRYVRGYQARCYAKFLRRTKAATIIQKYWRMYVVRRRYKIRRAATIVLQSYLRGFLARNRYRKILREHKAVIIQKRVRGWLARTHYKRSMHAIIYLQCCFRRMMAKRELKKLKIEARSVERYKKLHIGMENKIMQLQRKVDEQNKDYKCLVEKLTNLEGIYNSETEKLRSDLERLQLSEEEAKVATGRVLSLQEEIAKLRKDLEQTRSEKKCIEEHADRYKQETEQLVSNLKEENTLLKQEKEALNHRIVQQAKEMTETMEKKLVEETKQLELDLNDERLRYQNLLNEFSRLEERYDDLKEEMTLMVHVPKPGHKRTDSTHSSNESEYIFSSEIAEMEDIPSRTEEPSEKKVPLDMSLFLKLQKRVTELEQEKQVMQDELDRKEEQVLRSKAKEEERPQIRGAELEYESLKRQELESENKKLKNELNELRKALSEKSAPEVTAPGAPAYRVLMEQLTSVSEELDVRKEEVLILRSQLVSQKEAIQPKDDKNTMTDSTILLEDVQKMKDKGEIAQAYIGLKETNRSSALDYHELNEDGELWLVYEGLKQANRLLESQLQSQKRSHENEAEALRGEIQSLKEENNRQQQLLAQNLQLPPEARIEASLQHEITRLTNENLDLMEQLEKQDKTVRKLKKQLKVFAKKIGELEVGQMENISPGQIIDEPIRPVNIPRKEKDFQGMLEYKKEDEQKLVKNLILELKPRGVAVNLIPGLPAYILFMCVRHADYLNDDQKVRSLLTSTINSIKKVLKKRGDDFETVSFWLSNTCRFLHCLKQYSGEEGFMKHNTSRQNEHCLTNFDLAEYRQVLSDLAIQIYQQLVRVLENILQPMIVSGMLEHETIQGVSGVKPTGLRKRTSSIADEGTYTLDSILRQLNSFHSVMCQHGMDPELIKQVVKQMFYIIGAITLNNLLLRKDMCSWSKGMQIRYNVSQLEEWLRDKNLMNSGAKETLEPLIQAAQLLQVKKKTDDDAEAICSMCNALTTAQIVKVLNLYTPVNEFEERVSVSFIRTIQMRLRDRKDSPQLLMDAKHIFPVTFPFNPSSLALETIQIPASLGLGFISRV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAASELYTK
------CCHHHHHHH
30.8822814378
9UbiquitinationAASELYTKFARVWIP
CHHHHHHHHCCCCCC
24.38-
9 (in isoform 3)Ubiquitination-24.38-
31PhosphorylationSAELLKDYKPGDKVL
HHHHHHCCCCCCEEE
19.93-
169UbiquitinationSGESGAGKTVSAKYA
ECCCCCCCCHHHHHH
45.26-
170PhosphorylationGESGAGKTVSAKYAM
CCCCCCCCHHHHHHH
20.8322210691
172PhosphorylationSGAGKTVSAKYAMRY
CCCCCCHHHHHHHHH
25.0320068231
175PhosphorylationGKTVSAKYAMRYFAT
CCCHHHHHHHHHHHE
12.8320068231
182PhosphorylationYAMRYFATVSGSASE
HHHHHHHEECCCCCC
12.8122210691
184PhosphorylationMRYFATVSGSASEAN
HHHHHEECCCCCCCC
23.7522210691
188PhosphorylationATVSGSASEANVEEK
HEECCCCCCCCHHHH
38.6524719451
199PhosphorylationVEEKVLASNPIMESI
HHHHHHHCCHHHHHH
38.69-
205PhosphorylationASNPIMESIGNAKTT
HCCHHHHHHCCCCCC
20.5828634298
211PhosphorylationESIGNAKTTRNDNSS
HHHCCCCCCCCCCCC
28.6928634298
212PhosphorylationSIGNAKTTRNDNSSR
HHCCCCCCCCCCCCC
27.1128634298
217PhosphorylationKTTRNDNSSRFGKYI
CCCCCCCCCCCEEEE
26.2529514088
218PhosphorylationTTRNDNSSRFGKYIE
CCCCCCCCCCEEEEE
37.5729514088
222AcetylationDNSSRFGKYIEIGFD
CCCCCCEEEEEEECC
40.1022424773
241PhosphorylationIIGANMRTYLLEKSR
EECCCHHHHHHHHCE
14.0429083192
242PhosphorylationIGANMRTYLLEKSRV
ECCCHHHHHHHHCEE
10.0229083192
246UbiquitinationMRTYLLEKSRVVFQA
HHHHHHHHCEEEEEC
43.46-
247PhosphorylationRTYLLEKSRVVFQAE
HHHHHHHCEEEEECH
22.4129083192
289UbiquitinationADNFNYTKQGGSPVI
CCCCCCCCCCCCCEE
36.26-
293PhosphorylationNYTKQGGSPVIEGVD
CCCCCCCCCEEECCC
23.8725262027
379MalonylationCHWLCHRKLATATET
HHHHHHCHHHCCCCC
20.8626320211
382PhosphorylationLCHRKLATATETYIK
HHHCHHHCCCCCCCC
44.5429449344
384PhosphorylationHRKLATATETYIKPI
HCHHHCCCCCCCCCH
25.2229449344
386PhosphorylationKLATATETYIKPISK
HHHCCCCCCCCCHHH
26.6229449344
387PhosphorylationLATATETYIKPISKL
HHCCCCCCCCCHHHH
10.7529449344
389MalonylationTATETYIKPISKLQA
CCCCCCCCCHHHHHC
26.3626320211
477PhosphorylationFKLEQEEYMKEQIPW
HHHCHHHHHHHHCCC
16.8530177828
522PhosphorylationMPKGTDDTWAQKLYN
CCCCCCCHHHHHHHH
26.0529759185
528PhosphorylationDTWAQKLYNTHLNKC
CHHHHHHHHHHCCCC
25.6729759185
530PhosphorylationWAQKLYNTHLNKCAL
HHHHHHHHHCCCCCC
17.7429759185
600PhosphorylationQDDEKAISPTSATSS
CCCCCCCCCCCCCCC
27.3030266825
602PhosphorylationDEKAISPTSATSSGR
CCCCCCCCCCCCCCC
24.9730266825
603PhosphorylationEKAISPTSATSSGRT
CCCCCCCCCCCCCCC
32.6930266825
605PhosphorylationAISPTSATSSGRTPL
CCCCCCCCCCCCCCC
24.1623403867
606PhosphorylationISPTSATSSGRTPLT
CCCCCCCCCCCCCCC
30.4327486199
610PhosphorylationSATSSGRTPLTRTPA
CCCCCCCCCCCCCCC
26.6121712546
613PhosphorylationSSGRTPLTRTPAKPT
CCCCCCCCCCCCCCC
33.4323898821
615PhosphorylationGRTPLTRTPAKPTKG
CCCCCCCCCCCCCCC
23.5121712546
653PhosphorylationLMETLNATTPHYVRC
HHHHHCCCCCCEEEE
39.52-
671PhosphorylationNDFKFPFTFDEKRAV
CCCCCCCCCCHHHHH
30.3430242111
721PhosphorylationMKQKDVLSDRKQTCK
HHHHHHHCCHHHHHH
34.9123312004
757PhosphorylationFRAGQVAYLEKLRAD
EEHHHHHHHHHHCHH
19.28-
828PhosphorylationIQKYWRMYVVRRRYK
HHHHHHHHHHHHHHH
6.29-
834PhosphorylationMYVVRRRYKIRRAAT
HHHHHHHHHHHHHHH
14.68-
846PhosphorylationAATIVLQSYLRGFLA
HHHHHHHHHHHHHHH
23.2124719451
902AcetylationCFRRMMAKRELKKLK
HHHHHHHHHHHHHCC
28.637681477
918PhosphorylationEARSVERYKKLHIGM
CHHHHHHHHHHHHHH
10.04-
943PhosphorylationVDEQNKDYKCLVEKL
HHHCCCCHHHHHHHH
12.7630576142
979UbiquitinationQLSEEEAKVATGRVL
HCCHHHHHHHHHHHH
35.36-
982PhosphorylationEEEAKVATGRVLSLQ
HHHHHHHHHHHHHHH
28.6329255136
987PhosphorylationVATGRVLSLQEEIAK
HHHHHHHHHHHHHHH
25.75-
1028UbiquitinationEQLVSNLKEENTLLK
HHHHHHHHHHCHHHH
68.20-
1032PhosphorylationSNLKEENTLLKQEKE
HHHHHHCHHHHHHHH
36.4323312004
1050MethylationHRIVQQAKEMTETME
HHHHHHHHHHHHHHH
43.62115973545
1055PhosphorylationQAKEMTETMEKKLVE
HHHHHHHHHHHHHHH
22.8226546556
1058UbiquitinationEMTETMEKKLVEETK
HHHHHHHHHHHHHHH
40.35-
1078PhosphorylationLNDERLRYQNLLNEF
CCHHHHHHHHHHHHH
13.32-
1086PhosphorylationQNLLNEFSRLEERYD
HHHHHHHHHHHHHHH
29.76-
1113PhosphorylationPKPGHKRTDSTHSSN
CCCCCCCCCCCCCCC
38.8224043423
1113 (in isoform 3)Phosphorylation-38.8221406692
1115PhosphorylationPGHKRTDSTHSSNES
CCCCCCCCCCCCCCC
27.6622617229
1115 (in isoform 3)Phosphorylation-27.6621406692
1116PhosphorylationGHKRTDSTHSSNESE
CCCCCCCCCCCCCCC
28.6922617229
1118PhosphorylationKRTDSTHSSNESEYI
CCCCCCCCCCCCCEE
34.6422617229
1119PhosphorylationRTDSTHSSNESEYIF
CCCCCCCCCCCCEEE
36.6924043423
1119 (in isoform 3)Phosphorylation-36.6921406692
1122PhosphorylationSTHSSNESEYIFSSE
CCCCCCCCCEEEEHH
39.6927251789
1124PhosphorylationHSSNESEYIFSSEIA
CCCCCCCEEEEHHHH
19.2828450419
1127PhosphorylationNESEYIFSSEIAEME
CCCCEEEEHHHHCCC
19.9421406692
1128PhosphorylationESEYIFSSEIAEMED
CCCEEEEHHHHCCCC
23.4421406692
1138PhosphorylationAEMEDIPSRTEEPSE
HCCCCCCCCCCCCCC
52.7727251789
1138 (in isoform 3)Phosphorylation-52.7721406692
1140PhosphorylationMEDIPSRTEEPSEKK
CCCCCCCCCCCCCCC
49.3821406692
1144PhosphorylationPSRTEEPSEKKVPLD
CCCCCCCCCCCCCCC
66.3921406692
1153PhosphorylationKKVPLDMSLFLKLQK
CCCCCCHHHHHHHHH
18.6826270265
1203PhosphorylationIRGAELEYESLKRQE
CCCCHHHHHHHHHHH
24.3628796482
1205PhosphorylationGAELEYESLKRQELE
CCHHHHHHHHHHHHH
37.9929255136
1207AcetylationELEYESLKRQELESE
HHHHHHHHHHHHHHH
62.4018530817
1207UbiquitinationELEYESLKRQELESE
HHHHHHHHHHHHHHH
62.40-
1213PhosphorylationLKRQELESENKKLKN
HHHHHHHHHHHHHHH
60.1216097034
1232UbiquitinationLRKALSEKSAPEVTA
HHHHHHHCCCCCCCC
48.84-
1233PhosphorylationRKALSEKSAPEVTAP
HHHHHHCCCCCCCCC
45.0322210691
1245PhosphorylationTAPGAPAYRVLMEQL
CCCCCHHHHHHHHHH
10.5318083107
1253PhosphorylationRVLMEQLTSVSEELD
HHHHHHHHCCCHHCC
27.1227251275
1254PhosphorylationVLMEQLTSVSEELDV
HHHHHHHCCCHHCCC
32.0427251275
1256PhosphorylationMEQLTSVSEELDVRK
HHHHHCCCHHCCCCH
25.7227251275
1312PhosphorylationKGEIAQAYIGLKETN
CCCHHHHHHCCCCCC
5.3928674419
1339PhosphorylationDGELWLVYEGLKQAN
CCCEEEHHHHHHHHH
11.34-
1355PhosphorylationLLESQLQSQKRSHEN
HHHHHHHHHHHHHHH
46.3825332170
1400PhosphorylationPEARIEASLQHEITR
HHHHHHHHHHHHHHH
18.7718452278
1409PhosphorylationQHEITRLTNENLDLM
HHHHHHHHHHCHHHH
36.8820068231
1416SulfoxidationTNENLDLMEQLEKQD
HHHCHHHHHHHHHHH
2.8521406390
1452PhosphorylationVGQMENISPGQIIDE
CCCCCCCCCCCCCCC
34.2629255136
14802-HydroxyisobutyrylationFQGMLEYKKEDEQKL
CCHHHHCCHHHHHHH
40.07-
1511PhosphorylationLIPGLPAYILFMCVR
CCCCCCHHHHHHHHH
9.0227251275
1531PhosphorylationNDDQKVRSLLTSTIN
CCHHHHHHHHHHHHH
30.6220068231
1534PhosphorylationQKVRSLLTSTINSIK
HHHHHHHHHHHHHHH
29.1720068231
1535PhosphorylationKVRSLLTSTINSIKK
HHHHHHHHHHHHHHH
27.5320068231
1536PhosphorylationVRSLLTSTINSIKKV
HHHHHHHHHHHHHHH
20.9520068231
1539PhosphorylationLLTSTINSIKKVLKK
HHHHHHHHHHHHHHH
31.7520068231
1572PhosphorylationLHCLKQYSGEEGFMK
HHHHHHHCCCCCCCC
36.92-
1650PhosphorylationPTGLRKRTSSIADEG
CCCCCHHCCCCCCCC
29.8429255136
1651PhosphorylationTGLRKRTSSIADEGT
CCCCHHCCCCCCCCC
24.6329255136
1652PhosphorylationGLRKRTSSIADEGTY
CCCHHCCCCCCCCCC
22.6029255136
1658PhosphorylationSSIADEGTYTLDSIL
CCCCCCCCCCHHHHH
15.9830278072
1659PhosphorylationSIADEGTYTLDSILR
CCCCCCCCCHHHHHH
19.0323403867
1660PhosphorylationIADEGTYTLDSILRQ
CCCCCCCCHHHHHHH
24.7523403867
1663PhosphorylationEGTYTLDSILRQLNS
CCCCCHHHHHHHHHC
27.0023403867
1743PhosphorylationMNSGAKETLEPLIQA
CCCCHHHHHHHHHHH
35.40-
1760PhosphorylationLLQVKKKTDDDAEAI
HHHHHCCCCCCHHHH
54.2421082442

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MYO5A_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MYO5A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MYO5A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MELPH_HUMANMLPHphysical
14730011
DYL1_HUMANDYNLL1physical
10844022
DYL2_HUMANDYNLL2physical
10844022
RB27A_HUMANRAB27Aphysical
12006666
DYL2_HUMANDYNLL2physical
11546872
MELPH_HUMANMLPHphysical
12062444
EXOC3_HUMANEXOC3physical
22172676
EXOC4_HUMANEXOC4physical
22172676
MYH11_HUMANMYH11physical
26344197
PLST_HUMANPLS3physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
214450Griscelli syndrome 1 (GS1)
609227Griscelli syndrome 3 (GS3)
256710Elejalde syndrome (ELEJAS)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MYO5A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600, AND MASSSPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1213, AND MASSSPECTROMETRY.

TOP